On August 17th, 2016, Virginia Contract Research Organization Co., Ltd. (VCRO) obtained a phase I IND clinical-go in pain control area from the US FDA, for a sponsor based in China. This IND package was prepared and submitted in common technical document (CTD) format and there was no technical question was asked during the 30 days review. The accomplishment has opened an new era on the Taiwan-China cooperation in new drug development to the world.
Congratulations! VCRO submitted an IND for a novel product in pain control was accepted by the US FDA
On August 17th, 2016, Virginia Contract Research Organization Co., Ltd. (VCRO) obtained a phase I IND clinical-go in pain control area from the US FDA, for a sponsor based in China. This IND package was prepared and submitted in common technical document (CTD) format and there was no technical question was asked during the 30…